The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis
- PMID: 16165011
- DOI: 10.1016/j.tcm.2005.05.006
The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis
Abstract
Caveolae are plasmalemmal invaginations formed by the sequestration of cholesterol and glycosphingolipids with self-associating molecules named caveolins, resulting in a platform for the assembly of signaling complexes at the surface of the cell. The enrichment of the endothelial nitric oxide synthase in caveolae and its direct interaction with caveolin both account for the exquisite regulation of nitric oxide production in cardiovascular tissues. Dissection of the angiogenic signaling cascade downstream vascular endothelial growth factor recently led to recognition that although the former enables the compartmentation of endothelial nitric oxide synthase and optimizes the process leading to its activation, the latter maintains the enzyme in its inactivated state in the absence of stimulation. Alteration in caveolin abundance or subcellular location may lead endothelial cells or cardiac myocytes to favor one mode of regulation over the other and thereby alter the subtle equilibrium governing nitric oxide production in these cells.
Similar articles
-
Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.Circ Res. 2004 Jul 23;95(2):154-61. doi: 10.1161/01.RES.0000136344.27825.72. Epub 2004 Jun 17. Circ Res. 2004. PMID: 15205364
-
The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.Cardiovasc Res. 2006 Aug 1;71(3):478-85. doi: 10.1016/j.cardiores.2006.04.013. Epub 2006 Apr 27. Cardiovasc Res. 2006. PMID: 16814758
-
Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.J Physiol Pharmacol. 2009 Oct;60 Suppl 4:105-9. J Physiol Pharmacol. 2009. PMID: 20083858 Review.
-
Caveolins and the regulation of endothelial nitric oxide synthase in the heart.Cardiovasc Res. 2006 Mar 1;69(4):788-97. doi: 10.1016/j.cardiores.2005.12.014. Cardiovasc Res. 2006. PMID: 16483868 Review.
-
Caveolin, caveolae, and endothelial cell function.Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1161-8. doi: 10.1161/01.ATV.0000070546.16946.3A. Epub 2003 Apr 10. Arterioscler Thromb Vasc Biol. 2003. PMID: 12689915 Review.
Cited by
-
Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.Am J Pathol. 2012 Apr;180(4):1702-14. doi: 10.1016/j.ajpath.2011.12.018. Epub 2012 Feb 7. Am J Pathol. 2012. PMID: 22322296 Free PMC article.
-
Caveolin-1, caveolae, and glioblastoma.Neuro Oncol. 2012 Jun;14(6):679-88. doi: 10.1093/neuonc/nos079. Epub 2012 Apr 16. Neuro Oncol. 2012. PMID: 22508761 Free PMC article. Review.
-
Heritable forms of pulmonary arterial hypertension.Semin Respir Crit Care Med. 2013 Oct;34(5):568-80. doi: 10.1055/s-0033-1355443. Epub 2013 Sep 13. Semin Respir Crit Care Med. 2013. PMID: 24037626 Free PMC article.
-
Caveolin-1 Scaffolding Domain Peptide Regulates Colon Endothelial Cell Survival through JNK Pathway.Int J Inflam. 2020 Mar 6;2020:6150942. doi: 10.1155/2020/6150942. eCollection 2020. Int J Inflam. 2020. PMID: 35013693 Free PMC article.
-
Ca²⁺-dependent nitric oxide release in the injured endothelium of excised rat aorta: a promising mechanism applying in vascular prosthetic devices in aging patients.BMC Surg. 2013;13 Suppl 2(Suppl 2):S40. doi: 10.1186/1471-2482-13-S2-S40. Epub 2013 Oct 8. BMC Surg. 2013. PMID: 24266895 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources